The Hyp mouse, a model for human X-linked hypophosphatemia (XLH), is c
haracterized by phosphate wasting and defective mineralization. Since
osteopontin (OPN) is considered pivotal for biological mineralization,
rye examined the biosynthesis of OPN in osteoblasts of +/Y and Hyp/Y
mice. Immunoprecipitation analyses using a specific antibody to OPN re
vealed that Hyp/Y and +/Y osteoblasts secrete similar levels of OPN as
determined but [S-35]-methionine biosynthetic labeling, but a reduced
phosphorylation was noted after P-32-PO4 biosynthetic labeling. North
ern blot hybridization analysis of +/Y and Hyp/Y mice osteoblast mRNAs
, using a cDNA probe for mouse OPN, revealed no difference in the stea
dy state levels of osteopontin mRNA. Analysis of casein kinase II acti
vity in +/Y and Hyp/Y mice osteoblast, kidney, heart and liver membran
e fractions revealed that casein kinase II activity in the Hyp/Y mice
osteoblasts and kidney is only 35%-50%, respectively, of that of the /Y mice tissues. The accumulated data are consistent with a post-trans
lational defect in the Hyp/Y mouse osteoblast which results in the und
erphosphorylation of osteopontin and subsequent undermineralization of
bone matrix.